메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 25, Issue 30, 2007, Pages 4861-
Radiotherapy for locally advanced pancreatic cancer [11]
Author keywords

[No Author keywords available]
Indexed keywords

ANTINEOPLASTIC AGENT;
EID: 36048968814     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.13.0054     Document Type: Letter
Times cited : (3)
References (7)
  • 1
    • 34249100896 scopus 로고    scopus 로고
    • Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700
    • Isacoff WH, Bendetti JK, Barstis JJ, et al: Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. J Clin Oncol 25:1665-1669, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 1665-1669
    • Isacoff, W.H.1    Bendetti, J.K.2    Barstis, J.J.3
  • 2
    • 0035890443 scopus 로고    scopus 로고
    • Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer
    • McGinn CJ, Zalupski MM, Shureiqi I, et al: Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol 19:4202-4208, 2001
    • (2001) J Clin Oncol , vol.19 , pp. 4202-4208
    • McGinn, C.J.1    Zalupski, M.M.2    Shureiqi, I.3
  • 3
    • 1342289781 scopus 로고    scopus 로고
    • Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer
    • Muler JH, McGinn CJ, Normolle D, et al: Phase I trial using a time-to-event continual reassessment strategy for dose escalation of cisplatin combined with gemcitabine and radiation therapy in pancreatic cancer. J Clin Oncol 22:238-243, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 238-243
    • Muler, J.H.1    McGinn, C.J.2    Normolle, D.3
  • 4
    • 84871470955 scopus 로고    scopus 로고
    • A phase I study of oxaliplatin, full-dose gemcitabine and concurrent radiation therapy in patients with pancreatic cancer
    • abstr 4107, 204s
    • Desai S, et al: A phase I study of oxaliplatin, full-dose gemcitabine and concurrent radiation therapy in patients with pancreatic cancer. J Clin Oncol 24:204s, 2006 (abstr 4107)
    • (2006) J Clin Oncol , vol.24
    • Desai, S.1
  • 5
    • 34249332089 scopus 로고    scopus 로고
    • Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer
    • Murphy JD, Adusumilli S, Griffith KA, et al: Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys 68:801-808, 2007
    • (2007) Int J Radiat Oncol Biol Phys , vol.68 , pp. 801-808
    • Murphy, J.D.1    Adusumilli, S.2    Griffith, K.A.3
  • 6
    • 0015745990 scopus 로고
    • Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas
    • Haslam JB, Cavanaugh PJ, Stroup SL: Radiation therapy in the treatment of irresectable adenocarcinoma of the pancreas. Cancer 32:1341-1345, 1973
    • (1973) Cancer , vol.32 , pp. 1341-1345
    • Haslam, J.B.1    Cavanaugh, P.J.2    Stroup, S.L.3
  • 7
    • 0023722682 scopus 로고
    • Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone: Gastrointestinal Tumor Study Group
    • Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone: Gastrointestinal Tumor Study Group. J Natl Cancer Inst 80:751-755, 1988
    • (1988) J Natl Cancer Inst , vol.80 , pp. 751-755

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.